Skip to main content

Want a detailed portfolio tracker?

Reneo Pharmaceuticals (OKUR) P/E (2024 - 2026)

Reneo Pharmaceuticals (OKUR) P/E from Oct 7, 2024 to Jun 3, 2026. The TTM Reneo Pharmaceuticals (OKUR) P/E is -0.95. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Reneo Pharmaceuticals (OKUR)

YearP/EChange
2026-0.95+44.83%
2025-0.66-61.76%
2024-1.72N/A

Comparison Reneo Pharmaceuticals (OKUR) P/E with competitors

Reneo Pharmaceuticals (OKUR) P/E is -0.95.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.18%
NBYStablecoin Development Corp0.10-110.73%
ENLVEnlivex Therapeutics Ltd0.15-115.77%
FGENFibroGen Inc0.24-125.21%
TRAWTraws Pharma Inc0.47-149.65%
FBIOFortress Biotech Inc0.71-174.14%
CHRSCoherus Biosciences Inc0.98-202.71%
ORMPOramed Pharmaceuticals Inc1.47-254.72%
AGENAgenus Inc2.05-315.10%
VIVSVivoSim Labs Inc2.54-366.27%
INVAInnoviva Inc3.19-434.81%
CRMDCorMedix Inc3.65-482.82%
ABEOAbeona Therapeutics Inc4.20-541.55%
VXRTVaxart Inc4.26-547.49%
CVACCureVac N.V.4.45-566.82%
SRPTSarepta Therapeutics Inc4.62-585.57%
GLPGGalapagos NV4.86-610.21%
RIGLRigel Pharmaceuticals4.92-616.58%
ZVRAZevra Therapeutics Inc4.97-622.30%
ABUSArbutus Biopharma Corp5.69-697.88%
CGENCompugen Ltd7.38-875.36%
AUPHAurinia Pharmaceuticals Inc9.25-1071.47%
ACADAcadia Pharmaceuticals Inc9.59-1106.81%
OMEROmeros Corporation9.88-1137.83%
PLXProtalix BioTherapeutics Inc9.91-1140.53%
SPROSpero Therapeutics Inc10.73-1227.23%
ADMAAdma Biologics Inc11.33-1289.80%
SVASinovac Biotech Ltd11.44-1300.87%
TBPHTheravance Biopharma Inc11.78-1336.63%
HRMYHarmony Biosciences Holdings Inc12.18-1379.04%
TGTXTG Therapeutics Inc13.18-1483.94%
INCYIncyte Corp13.38-1505.22%
SABSSAB Biotherapeutics Inc14.06-1576.17%
XOMAXOMA Corp14.95-1669.37%
REGNRegeneron Pharmaceuticals Inc14.98-1673.04%
PBYIPuma Biotechnology Inc15.05-1680.41%
EXELExelixis Inc15.79-1758.58%
NAGENiagen Bioscience Inc16.35-1817.40%
CPRXCatalyst Pharmaceuticals Inc17.34-1921.33%
MDXGMimedx Group Inc17.38-1924.55%
ARGXArgen X SE23.07-2522.70%
HALOHalozyme Therapeutics Inc23.20-2536.24%
XOMAOXOMA Corp25.34-2761.40%
VRTXVertex Pharmaceuticals Inc25.66-2794.06%
XOMAPXOMA Corp25.67-2795.56%
CTMXCytomX Therapeutics Inc25.70-2798.48%
ASNDAscendis Pharma A/S26.35-2867.39%
RPRXRoyalty Pharma plc - Class A27.50-2987.24%
SLNOSoleno Therapeutics Inc29.02-3146.84%
LGNDLigand Pharmaceuticals Inc - Class B30.19-3269.82%
BMRNBiomarin Pharmaceutical Inc37.51-4038.56%
APLSApellis Pharmaceuticals Inc39.02-4197.53%
KRYSKrystal Biotech Inc39.70-4268.56%
GMABGenmab40.20-4321.70%
ONCBeiGene Ltd67.03-7138.37%
TECHBio-Techne Corp68.59-7303.03%
VCELVericel Corp80.63-8566.71%
PHARPharming Group N.V.87.74-9313.42%
ALNYAlnylam Pharmaceuticals Inc124.93-13219.04%
TLXTelix Pharmaceuticals Ltd139.89-14789.65%
CORTCorcept Therapeutics Inc158.39-16732.15%